News Detail
BENGALURU, 13 APRIL 2021: India's Cipla Ltd has doubled production of Covid-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave of infections, the drugmaker said on Tuesday.
India has overtaken Brazil as the worl......
View Details
Source : The Times of India
Related News
- CDSCO releases draft Guidance to align New Drugs and Clinical Trials Rules and SUGAM for stakeholder's comments (16-04-2024)
- Rise in AMR is leaving doctors with fewer options in drugs (16-04-2024)
- Significant decline in pharma deals in Q1 (16-04-2024)
- Falsified (contaminated) USP/EP PROPYLENE GLYCOL identified in the WHO Eastern Mediterranean Region (15-04-2024)
- Hyd: ACB nabs drug control official while taking ₹18K bribe (15-04-2024)
- More than 250 Websites selling fake Weight-Loss Drugs Reported by Anti-Counterfeit firm (15-04-2024)
- 'Ram Kit', available at many drugstores in Agra (15-04-2024)
- Sub-committee to look into one-time NOC and manufacturing license for unapproved, new drugs solely for exports (15-04-2024)
- DCC recommends ban on production & sale of chloramphenicol & nitrofurans for use in food-producing animals (15-04-2024)
- Monitoring of Adverse Events Following Immunisation improved in TN over last 10 years (15-04-2024)